Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience
Open Access
- 21 February 2018
- journal article
- research article
- Published by Bioscientifica in European Thyroid Journal
- Vol. 7 (3) , 149-154
Abstract
Objectives: Transaxillary robotic thyroidectomy surgery (TARS) has been reported to be a safe approach in patients with differentiated thyroid carcinoma, and oncological responses are promising. Study Design: This study aimed to evaluate the oncological outcomes of TARS followed by radioiodine (RAI) therapy in patients with differentiated thyroid carcinoma. Between 2011 and 2016, patients treated for differentiated thyroid carcinoma by TARS in a single institution, followed by RAI, were retrospectively included. The oncological response was performed according to the 2015 American Thyroid Association (ATA) guidelines 6–12 months later and at the last available visit. Results: A total of 42 patients (30 females) were included, with a median tumor size of 20 mm (12 cases of N1a and 5 cases of N1b on initial pathology report). According to ATA classification of recurrence risk after surgery, 17 and 25 patients were classified as low and intermediate risk, respectively. After RAI, all patients had a normal posttherapeutic whole body scan (except 1 patient, who had pathological lymph node uptake), but no unusual uptake was seen. At the 6- to 12-month evaluation (n = 37), 24 patients had excellent response, 8 had indeterminate response, and 5 had incomplete response (2 biological and 3 structural); no distant metastasis was found. At the last evaluation (median follow-up 15.9 months), 35 patients had no evidence of disease and 1 patient had a structural incomplete response. In total, a second open surgery was necessary for 3 patients to treat persistent lymph nodes (all intermediate risk). Conclusion: In this study, TARS followed by RAI therapy seems to be curative, even for patients with lymph node metastases, after good preoperative staging. More studies are required to confirm the findings.Keywords
This publication has 18 references indexed in Scilit:
- Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk PatientsEuropean Thyroid Journal, 2015
- Initial learning curve of single-incision transaxillary robotic hemi- and total thyroidectomy – A single team experience from EuropeInternational Journal of Surgery, 2015
- Robotic thyroidectomy versus conventional open thyroidectomy for differentiated thyroid cancer: meta-analysisThe Journal of Laryngology & Otology, 2015
- Surgical Safety and Oncologic Effectiveness in Robotic versus Conventional Open Thyroidectomy in Thyroid Cancer: A Systematic Review and Meta-AnalysisAnnals of Surgical Oncology, 2015
- A systematic review and meta‐analysis evaluating completeness and outcomes of robotic thyroidectomyThe Laryngoscope, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Indications for the Gasless Transaxillary Robotic Approach to Thyroid Surgery: Experience of Forty-Seven Procedures at the American Hospital of ParisEuropean Thyroid Journal, 2013
- A Comparison of Postoperative Pain After Conventional Open Thyroidectomy and Transaxillary Single-Incision Robotic Thyroidectomy: A Prospective StudyAnnals of Surgical Oncology, 2013
- Comparison of the incidence of postoperative nausea and vomiting between women undergoing open or robot-assisted thyroidectomySurgical Endoscopy, 2012
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009